229 related articles for article (PubMed ID: 12674617)
1. [A clinical and pathological study on primary oral mucosal malignant melanoma].
Chen Y; He Z; Wu L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Feb; 21(1):31-3. PubMed ID: 12674617
[TBL] [Abstract][Full Text] [Related]
2. Tumor size and depth in primary malignant melanoma in the oral cavity influences survival.
Mücke T; Hölzle F; Kesting MR; Loeffelbein DJ; Robitzky LK; Hohlweg-Majert B; Tannapfel A; Wolff KD
J Oral Maxillofac Surg; 2009 Jul; 67(7):1409-15. PubMed ID: 19531410
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
Tas F; Kurul S; Camlica H; Topuz E
Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
[TBL] [Abstract][Full Text] [Related]
4. Oral malignant melanoma: the amsterdam experience.
Meleti M; Leemans CR; Mooi WJ; van der Waal I
J Oral Maxillofac Surg; 2007 Nov; 65(11):2181-6. PubMed ID: 17954312
[TBL] [Abstract][Full Text] [Related]
5. [Fourteen cases of mucosal melanomas of the oral cavity].
Notani K; Shindo M; Mizukoshi T; Yamashita T; Totsuka Y; Fukuda H; Amemiya A
Gan No Rinsho; 1987 Feb; 33(2):129-37. PubMed ID: 3560447
[TBL] [Abstract][Full Text] [Related]
6. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
[TBL] [Abstract][Full Text] [Related]
7. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
8. Primary malignant melanoma of the oral mucosa.
Chidzonga MM; Mahomva L; Marimo C; Makunike-Mutasa R
J Oral Maxillofac Surg; 2007 Jun; 65(6):1117-20. PubMed ID: 17517294
[TBL] [Abstract][Full Text] [Related]
9. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
[TBL] [Abstract][Full Text] [Related]
10. Oral mucosal melanoma: a series of case reports.
Garzino-Demo P; Fasolis M; Maggiore GM; Pagano M; Berrone S
J Craniomaxillofac Surg; 2004 Aug; 32(4):251-7. PubMed ID: 15262258
[TBL] [Abstract][Full Text] [Related]
11. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
[TBL] [Abstract][Full Text] [Related]
12. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
13. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].
Li XM; DI B; Shang YD; Li J; Cheng JM
Ai Zheng; 2005 Feb; 24(2):208-12. PubMed ID: 15694035
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and prognosis of primary nasal mucosal melanoma--a report of 44 cases].
Peng RQ; Wu GH; Chen WK; Ding Y; Ma J; Zhang NH; Su YS; Zhang XS
Ai Zheng; 2006 Oct; 25(10):1284-6. PubMed ID: 17059777
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.
Capote-Moreno A; Naval L; Muñoz-Guerra MF; Sastre J; Rodríguez-Campo FJ
J Oral Maxillofac Surg; 2010 Feb; 68(2):268-75. PubMed ID: 20116694
[TBL] [Abstract][Full Text] [Related]
17. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
18. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]